The global syringes market is expected to witness a dramatic rise in demand between 2025 and 2035, owing to rise in demand of medical devices for the purpose of drug administration, among various end-use sectors such as hospitals, home-care setting, and vaccination and chronic disease management programs.
Factors such as increasing healthcare spending, technological advancements in syringe and the increasing demand for safety and precision in healthcare delivery are driving the growth of the market. Moreover, the increasing use of disposable and prefilled syringes, and regulatory policies favoring infection control are other prominent factors driving the adoption across healthcare facilities globally.
Innovations such as smart syringes, biodegradable syringes, and needle-free delivery systems are further enhancing the market, meeting safety and sustainability challenges.
In 2025, the syringes market was valued at approximately USD 26,814.93 million. By 2035, it is projected to reach USD 63,480.71 million, reflecting a compound annual growth rate (CAGR) of 9%. The market growth is strongly driven by the rising prevalence of diabetes, immunization programs in emerging economies, and increased demand for self-administration of injectable drugs.
| Metric | Value |
|---|---|
| Market Size in 2025 | USD 26,814.93 Million |
| Projected Market Size in 2035 | USD 63,480.71 Million |
| CAGR (2025 to 2035) | 9% |
Technological advancements in polymer-based syringes, enhanced precision dosing mechanisms, and connectivity features for digital health integration are further contributing to market expansion. Companies are heavily investing in R&D to enhance product safety, improve material compatibility, and expand syringe applications in various medical fields.
Explore FMI!
Book a free demo
North America dominates the syringes market owing to the presence of sophisticated healthcare amenities, rapid adoption of progressive medical devices, and ongoing investments in R&D. Safety syringes, prefilled syringes, and biologics administration in the USA and Canada are in high demand.
Moreover, the market is being driven due to various government initiatives promoting vaccination programs and rigorous regulation of infection control. Other factors also are driving more syringes being used across the region, such as the rising prevalence of chronic diseases and the projected growth of outpatient care facilities.
Technological advancements, regulatory standards and high expenditure on healthcare are some of the key factors in Europe syringes market. Germany, France, and the UK lead the international market for syringe design developments, concentrating on such things as needle-stick injury prevention, precision dosing and drug compatibility. The further growth in biologics market, increasing aging population, and rising demand for self-injection devices are significant drivers propelling market growth.
The Asia-Pacific market is expected to grow rapidly due to increased healthcare access, automation in vaccine coverage, and increased government spending on healthcare. The introduction of advanced diagnostic tools and the increasing prevalence of infectious and chronic diseases will drive most of the South-East Asian market growth, especially in China, India, Japan, and South Korea.
Regional market growth is driven by the increasing demand for low-cost syringes, coupled with the improvement of manufacturing capability. Furthermore, the emergence of local syringe manufacturers and the growing knowledge of safe injection practices are also driving the market's trends.
Increase in adoption of innovative syringe technologies, rise in safety standards, and surge in demand for injectable drug delivery are expected to drive the global syringes market, which is projected to expand significantly over the next 10 years. Market participants are putting more attention on improving product safety, sustainability, and ease of use in response to the changing dynamics for healthcare professionals and patients around the world.
Stringent Regulatory Compliance and Quality Assurance
The syringes market is subject to stringent regulatory scrutiny with respect to safety, sterility, and material quality. Syringe manufacturing is done under strict guidelines laid down by regulatory authorities like the FDA, EMA, WHO, and all of them have rigid requirement for compliance with Good Manufacturing Practices (GMP) and quality certifications.
These rules raise the costs of production and extend the time frame for product approvals, presenting a barrier to market entry for new entrants. For manufacturers, staying compliant while being as cost-effective as possible continues to be a tough challenge to balance.
Environmental Concerns and Waste Management Issues
In recent years the rise in the use of disposable syringes made the generation of medical waste high leading to environmental implications. Treatment of plastic syringes is a major issue as their disposal is categorized as hazardous waste, which leads to regulatory and sustainability issues.
So the manufacturers are investing in biodegradable or recyclable alternatives as over the globe, governments are tightening waste management policies. Nonetheless, development of cost-effective, environmentally friendly syringe solution is still an industry's challenges.
Rising Demand for Safety Syringes
Safety syringes are experiencing an increasing demand due to the growing focus on infection control and needlestick injury prevention. These syringes also have retractable or shielded needles to prevent accidental needle sticks, which lowers rates of health-care-associated infection.
Growing implementation of safety regulations, regulations, and awareness programs by healthcare authorities for reducing the transmission of infections during surgical procedures is projected to create lucrative opportunities for manufacturers to address the need for advanced safety syringes for effective infection prevention.
Technological Advancements in Syringe Design
Syringe technology, such as prefilled syringes and smart syringes those that possess digital monitoring capability represent new innovations that are changing the industry. Prefilled syringes help increase the convenience for patients and the accuracy of drug administration, while smart syringes help in tracking dosage adherence and reducing misuse.
Introduction of digital technologies in syringes to assist chronic disease management and support self-administration, are also anticipated to create new avenues of growth in the market.
| Market Shift | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Compliance with sterilization and safety standards |
| Technological Advancements | Growth in prefilled and auto-disable syringes |
| Industry Adoption | Widespread adoption of disposable syringes |
| Supply Chain and Sourcing | Dependence on conventional plastic materials |
| Market Competition | Dominance of established syringe manufacturers |
| Market Growth Drivers | Demand for vaccination programs and disease management |
| Sustainability and Energy Efficiency | Initial focus on waste reduction policies |
| Integration of Smart Monitoring | Limited digital tracking of syringe usage |
| Advancements in Product Innovation | Development of ergonomic syringe designs |
| Market Shift | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | AI-driven regulatory monitoring and real-time compliance tracking |
| Technological Advancements | Expansion of smart syringes with IoT connectivity |
| Industry Adoption | Increased use of biodegradable and recyclable syringes |
| Supply Chain and Sourcing | Adoption of sustainable, eco-friendly raw materials |
| Market Competition | Rise of biotech firms specializing in innovative syringe solutions |
| Market Growth Drivers | Growth in self-administered drug therapies and remote healthcare |
| Sustainability and Energy Efficiency | Large-scale implementation of green manufacturing practices |
| Integration of Smart Monitoring | AI-enabled syringe monitoring for drug adherence |
| Advancements in Product Innovation | Personalized syringes with patient-specific dosing |
It is detrimental for the USA syringes to dominate the syringes market due to the need for vaccination programs, chronic disease management, and the availability of advanced healthcare infrastructure. Key growth drivers are the rising prevalence of diabetes and the growing adoption of self-injection devices.
Such factors, along with strict safety regulations to increase disposable and safety syringes market to grow. The presence of top syringes manufacturing companies followed by the government initiatives to support immunization programs.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 9.2% |
Factors such as increasing vaccination campaigns, growing home healthcare services, and rising awareness regarding infection control measures are driving the growth of the syringes market in the UK Prefilled syringes, as well as safety-engineered syringes, continue to pressure hospitals and clinics.
Needle-free injectors and other advancements in syringe technology are further impacting market trends as well. Furthermore, there are emphasis be put on high safety standards for syringe manufacturing and usage from the regulatory bodies such as the MHRA.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 8.8% |
Growing the geriatric population, increased prevalence of chronic disease like diabetes and cancer, and growing demand for advanced drug delivery systems are propelling the growth of the European Union's syringes market.
Germany, France, and Italy are prominent countries in this region. Significantly, the movement towards sustainable, eco-friendly medical devices, like biodegradable syringes, is influencing market dynamics. The significant government investment in healthcare infrastructure and increased efforts for the reduction of needle-stick injuries using safety syringes reinforce market growth.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union (EU) | 9% |
Japan is witnessing growth in syringes market due to the demographic factor of ageing population, high healthcare expenditure and greater needs for sophisticated healthcare technologies. The use of prefilled syringes for biologics and vaccines is increasing, driven by innovative drug delivery solutions receiving regulatory approval.
Market growth is also stimulated by Japan's strong pharmaceutical industry and a growing trend towards self-administered injections. Needle safety innovations, including retractable needles and ultra-thin syringes are also on the rise in the market.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 9.3% |
The syringe market in South Korea is growing as a result of the rapid expansion of its biotechnology and pharmaceutical industries. The key market drivers are the increasing prevalence of chronic diseases and the country’s growing emphasis on immunization programs.
The rising prevalence of undesired scenarios from syringes such as Jitters and needle stick injuries is propelling the demand for new designs of syringes such as auto-disable syringes and insulin pens. The other factors driving market growth are government efforts to make healthcare more accessible and to raise safety standards for medical devices.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 9.1% |
| Material Type | Market Share (2025) |
|---|---|
| Plastic Syringes | 71% |
Plastic, in most cases, dominates the market because they are cheap, lightweight, and easy to mass-produce. These syringes pick the most common syringe in hospitals, clinics and research laboratories because they have been used once and the risk of cross-contamination is reduced. Plastic syringes are safer, more durable, and easier to use than glass syringes.
Plastic syringes have long faced rising demand from barriers such as administration of drugs intravenously and programs for vaccinations. Moreover, manufacturers are also introducing eco-friendly and biodegradable plastics owing to strict regulations for medical waste management.
Technologies ranging from dose-tracking smart syringes to mobile devices are improving efficiency and patient safety. The plastic syringes market is projected to witness steady growth as separate healthcare policies which encourage better infection control measures are being adopted. Moreover, due to their economic advantage, they continue to be the products of choice in developing countries, where economics dictate medical procurement decisions.
Increasing occurrence of outpatient therapies and healthcare services in the home are also propelling the requesting prefilling syringes and user-friendly syringes for accurate dosing to reduce medicine wastage. The dominance of plastic syringes in the market is also complemented by growing government initiatives and funding towards mass immunization programmes.
| End-Use | Market Share (2025) |
|---|---|
| Hospitals | 60% |
The hospitals segment holds the highest market share in the syringes market owing to the high patient volume undergoing injections, vaccinations and IV treatment. Widely used within healthcare institutions, particularly hospitals, for general healthcare, emergency or critical procedures and chronic disease management, the daily consumption of syringes is the highest when compared to other specialized centers like research laboratories and clinical research centers.
The growing incidence of disease is increasing the demand for hospital syringes, as drug administration must be accurate and safe, for some conditions, such as diabetes or cancer. In fact, the government sponsored immunization drives and the increasing focus on prevention of infections have cemented the use of disposable syringes at hospitals. Prefilled syringes, which are increasingly being developed, also promise to greatly simplify the patient management by reducing preparation time and risk of medication errors.
The dominance of this segment is primarily driven by increased patient safety mechanisms and expansion of hospital infrastructure worldwide. As hospitals make a concerted effort to prevent the occurrence of nosocomial infections, the demand for single-use and safety syringes is expected to increase significantly in the coming years.
In addition, the increasing geriatric population and increasing cases of chronic illness are causing a surge in hospital admissions, resulting in higher demand for syringes in routine diagnostics and treatment. The construction of modern medical facilities and the rise in number of multispecialty hospitals globally supports the increased utilization of syringes in clinical environments.
Automated syringe disposal mechanisms are also placement together in hospitals to contribute towards sustainability and minimize biohazardous waste.
The demand for syringes is consistently growing owing to an increase in the number of vaccinations, an increase in chronic incidence, and advancements in safety available in syringe technology. The progressive use of disposable and auto-disable syringes is currently on the rise, fueled by healthcare regulations that are increasingly becoming stringent, focusing on infection control and patient safety.
They are highly focusing on implementing product innovations with more manufacturing capacity and adhering to strict medical device regulations to achieve this. Aid in the Market Dynamics with the Help of Technological Advancements in pre-filled syringes and smart drug delivery systems.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Becton, Dickinson and Company (BD) | 25-30% |
| Terumo Corporation | 18-22% |
| Nipro Corporation | 12-16% |
| Medtronic plc | 10-14% |
| Gerresheimer AG | 8-12% |
| Other Companies (combined) | 25-35% |
| Company Name | Key Offerings/Activities |
|---|---|
| Becton, Dickinson and Company (BD) | In 2025, Becton, Dickinson and Company (BD ) expanded its auto-disable syringe production capacity, catering to the growing demand for vaccination programs worldwide. The company also focused on developing syringes with enhanced patient safety features, ensuring better compliance with global health regulations. |
| Terumo Corporation | In 2024, Terumo Corporation introduced advanced polymer-based syringes, improving drug compatibility and reducing contamination risks. It also invested in expanding its production facilities, addressing the growing need for precision drug delivery systems worldwide. |
| Nipro Corporation | In 2025, Nipro Corporation launched next-generation pre-filled syringes, enhancing convenience and safety for healthcare providers. It also developed user-friendly syringe solutions to support the rise of self-administration drug therapies and personalized medicine approaches. |
| Medtronic plc | In 2024, Medtronic plc developed smart syringes with digital dose tracking, ensuring precision in medication administration. The company also invested in AI-driven analytics, optimizing drug delivery efficiency for both hospitals and home-care applications. |
| Gerresheimer AG | In 2025, Gerresheimer AG focused on sustainable syringe solutions, incorporating biodegradable materials for eco-friendly medical devices. Additionally, it developed advanced glass and polymer syringes to meet the rising demand for biologic drug applications. |
Key Company Insights
Becton, Dickinson and Company (BD) (25-30%)
BD holds global leadership for tube-based syringes, leveraging innovative design, safety-enhancement, and auto-disable technologies. They highlight the global characteristic to create an efficient supply chain process complemented with regulatory compliance, assuring its adoption in healthcare enhancement systems.
BD is also growing its partnerships with government vaccination program, enabling mass immunization efforts worldwide. The further investment in automated syringe production will improve efficiency for the company to meet the reporting surge in demand driven by emerging healthcare markets.
Terumo Corporation (18-22%)
Terumo high quality polymer syringes enhance biocompatibility with reduced leachables in drug formulations. The company spends on R&D for advanced drug delivery systems. The company has a strong foothold in injectable biologics as well as specialty syringes and is driving expansion today in relatively high growth emerging markets where there is increasing demand for prefilled and precision syringes.
The company is also using advanced automation capabilities to enhance syringe manufacturing processes.
Nipro Corporation (12-16%)
Nipro specializes in offering pre-fillable and high-precision syringes and customized solutions for pharmaceutical and biopharmaceutical applications. The company specializes in optimizing syringe designs and automating the manufacturing process.
Nipro is also committed to expanding its distribution network worldwide to enhance accessibility of its advanced syringe solutions across different healthcare settings. Nipro is optimizing patient and healthcare provider safety with ongoing advancements in the safety mechanisms of needles.
Medtronic plc (10-14%)
As a result, Medtronic has combined digital innovations with syringe technology and has built smart dose tracking and connected drug administration systems. It leading the way in AI-led precision medicine. Medtronic is also working on cloud-based patient monitoring systems that can track whether patients are taking their medication as directed in real-time. Example its small data drug delivery devices to increase-the prevent convenience of long-term therapy patients who repeatedly dose.
Gerresheimer AG (8-12%)
Our sustainable approach to medical devices involves production of syringes that are both biodegradable and environmentally friendly. Innovates with glass and polymer syringes to ensure sustainability in the long run. Pre-filled syringe technology will be improved too checked will be drug stability and contamination issues, Gerresheimer isolates.
The company's investment in regulatory compliance and strategic partnerships with pharmaceutical firms have positioned it as a leading provider of high-quality injectable packaging solutions.
Other Key Players (25-35% Combined)
Several other manufacturers contribute to the syringes market with diverse innovations:
The overall market size for syringes market was USD 26,814.93 million in 2025.
The syringes market expected to reach USD 63,480.71 million in 2035.
Rising prevalence of chronic diseases, expanding vaccination programs, increasing demand for safety syringes, technological advancements, and growing healthcare infrastructure will drive the syringes market demand.
The top 5 countries which drives the development of syringes market are USA, UK, Europe Union, Japan and South Korea.
Plastic syringes segment driving market growth to command significant share over the assessment period.
Sustainable Packaging Market Trends – Innovations & Growth 2025 to 2035
Ultra High Bond (UHB) Tape Market Analysis by Type, Thickness and End Use Through 2035
Thermoforming Machines Market Trends - Demand & Forecast 2025 to 2035
Strapping and Banding Equipment Market – Key Trends & Growth Outlook 2025 to 2035
Strapping Devices Market Trends - Size, Growth & Forecast 2025 to 2035
Specialty Pulp and Paper Chemicals Market Analysis – Growth & Forecast 2025 to 2035
Syringes Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
